REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr. Max 118 s.r.o. (Slovakia)

Main Activities: Pharmacies and Drug Stores
Full name: Dr. Max 118 s.r.o. Profile Updated: January 31, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Dr. Max 118 s.r.o. is based in Slovakia, with the head office in Kosice. The enterprise operates in the Pharmacies and Drug Stores industry. The company was established on October 19, 2016. The total number of employees is currently 5 - 9 (2023). In its most recent financial highlights, the company reported a net sales revenue increase of 4.97% in 2023. Over the same period, its total assets decreased by 3.72%. The net profit margin of Dr. Max 118 s.r.o. decreased by 0.79% in 2023.

Headquarters
Moldavska cesta 8/A
Kosice; Kosicky; Postal Code: 04011

Contact Details: Purchase the Dr. Max 118 s.r.o. report to view the information.

Basic Information
Total Employees:
Purchase the Dr. Max 118 s.r.o. report to view the information.
Outstanding Shares:
Purchase the Dr. Max 118 s.r.o. report to view the information.
Registered Capital:
Purchase the Dr. Max 118 s.r.o. report to view the information.
Incorporation Date:
October 19, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Dr. Max 118 s.r.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
4.97%
Total operating revenue
3.9%
Operating profit (EBIT)
-36%
EBITDA
-21.35%
Net Profit (Loss) for the Period
-43.38%
Total assets
-3.72%
Total equity
11.13%
Operating Profit Margin (ROS)
-1.02%
Net Profit Margin
-0.79%
Return on Equity (ROE)
-9.64%
Debt to Equity Ratio
-0.04%
Quick Ratio
0.15%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?